News & Events
Fingolimod safety and efficacy confirmed
The results of a seven-year follow-up study confirm the safety and efficacy of fingolimod
Exclusive breastfeeding is safe following childbirth
A German study shows that exclusive breastfeeding does not increase the risk of relapse after childbirth
MSIF and ECTRIMS hold first joint alumni event
Current and past fellows of MSIF and ECTRIMS come together in Barcelona to share experiences
Can Melatonin improve MS?
Study suggests that melatonin could be a possible cause of seasonal changes in MS disease activity
MSIF is seeking a Research Insight Analyst
We are seeking a Research Insight Analyst for a project this November
Polish ‘Symphony of Hearts’ shows people what it’s like to experience symptoms of MS
Awareness day by the Polish MS Society teaches the public about MS
International Progressive MS Alliance funds global research collaboration
Collaborative Network Planning Awards Granted as part of €22 million global effort to End Progressive MS
Get Wet for MS makes a splash in Spain
Get Wet for MS is an annual awareness raising campaign by EME. It's a series of events…
ARSEP is working with photographer Dorothy Shoes to exhibit her work on MS
Dorothy Shoes uses her photography to demonstrate the impact MS has on her life
Highlights from the ‘Living with MS Day’
On 6 October, 650 people affected by MS gathered in Barcelona for the ‘Living with MS Day’…
What happened at ECTRIMS 2015?
Our highlights from the world’s largest scientific conference on multiple sclerosis
Positive results for people with primary progressive MS
The results from a phase III clinical trial of Ocrelizumab in primary progressive MS are announced at…